Airede

Shanghai Airede Biotechnology Co., Ltd. was established in 2012 and is located in the Caohejing High-Tech Park, Minhang District, Shanghai. Adhering to the mission of "bringing quality diagnostic products to everyone," the company has, over 10 years of development, established cooperative relationships with over 500 domestic and international hospitals, leveraging superior service, leading technology, and excellent functionality. Collaborating with renowned academic institutions such as Harvard University, Yale University, University of Tokyo, Shanghai Jiao Tong University, Fudan University, the Chinese Academy of Sciences, and leading enterprises in the United States, Germany, Japan, and other countries within the industry, Airede has co-created advanced IVD platforms and now holds over 50 national intellectual property rights.
Airede is dedicated to cutting-edge biotechnology research in areas such as colloidal gold and fluorescence immunoassay. It has developed and successfully launched test kits for high-sensitivity C-reactive protein (hs-CRP), procalcitonin (PCT), B-type natriuretic peptide (BNP), and a cardiac panel, as well as dry immunoassay analyzers and fully automated sample processing systems, forming a complete R&D, manufacturing, and sales chain for in-vitro diagnostics.
Adhering to the principles of openness, transparency, truth-seeking, simplicity, and mutual achievement, Airede has received honors such as "Exceptional Employer" and "Specialized, Refined, Distinctive, and Innovative" enterprise qualifications in Shanghai. Rooted in customer needs and providing high-quality products, the company is committed to becoming an outstanding service provider in the global in-vitro diagnostics industry.